- Home
- IVVD vs NODK Comparison
IVVD vs NODK Comparison
Compare IVVD & NODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVVD
- NODK
- Stock Information
- Founded
- IVVD 2020
- NODK 1946
- Country
- IVVD United States
- NODK United States
- Employees
- IVVD N/A
- NODK N/A
- Industry
- IVVD Biotechnology: Pharmaceutical Preparations
- NODK Property-Casualty Insurers
- Sector
- IVVD Health Care
- NODK Finance
- Exchange
- IVVD Nasdaq
- NODK Nasdaq
- Market Cap
- IVVD 351.6M
- NODK 289.0M
- IPO Year
- IVVD 2021
- NODK 2017
- Fundamental
- Price
- IVVD $1.75
- NODK $13.55
- Analyst Decision
- IVVD Strong Buy
- NODK
- Analyst Count
- IVVD 5
- NODK 0
- Target Price
- IVVD $5.11
- NODK N/A
- AVG Volume (30 Days)
- IVVD 5.6M
- NODK 9.9K
- Earning Date
- IVVD 11-13-2025
- NODK 11-06-2025
- Dividend Yield
- IVVD N/A
- NODK N/A
- EPS Growth
- IVVD N/A
- NODK N/A
- EPS
- IVVD N/A
- NODK 0.07
- Revenue
- IVVD $46,210,000.00
- NODK $310,389,000.00
- Revenue This Year
- IVVD $112.35
- NODK N/A
- Revenue Next Year
- IVVD $272.14
- NODK N/A
- P/E Ratio
- IVVD N/A
- NODK $191.70
- Revenue Growth
- IVVD 1941.08
- NODK N/A
- 52 Week Low
- IVVD $0.35
- NODK $12.01
- 52 Week High
- IVVD $2.74
- NODK $17.24
- Technical
- Relative Strength Index (RSI)
- IVVD 64.77
- NODK 53.97
- Support Level
- IVVD $1.56
- NODK $13.02
- Resistance Level
- IVVD $2.01
- NODK $13.77
- Average True Range (ATR)
- IVVD 0.19
- NODK 0.27
- MACD
- IVVD 0.03
- NODK -0.00
- Stochastic Oscillator
- IVVD 72.92
- NODK 54.89
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About NODK NI Holdings Inc.
NI Holdings Inc is a stockholding company. The company's operating segments include private passenger auto insurance, non-standard auto insurance, home and farm insurance, crop insurance, commercial insurance, and others. The company operates only in USA.